Evidence map›Paper›PMID 32727407›Full record

ArticleBMC cancer2020

Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years.

Zoltán Lőcsei, Róbert Farkas, Kornélia Borbásné Farkas, Klára Sebestyén, Zsolt Sebestyén, Zoltán Musch, Ágnes Vojcek, Noémi Benedek, László Mangel, Gábor Ottóffy

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Craniospinal irradiation planning and delivery: a comparison between Halcyon Ring Gantry and TrueBeam C Arm LINAC delivery systems.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
  2. Dynamics and predictors of hematologic toxicity during cranio-spinal irradiation.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zoltán LőcseiClinical Center, Department of Oncotherapy, University of Pécs, Édesanyák útja 17, Pécs, 7624, Hungary. locsei.zoltan@pte.hu.ORCID http://orcid.org/0000-0003-2569-5235
Róbert FarkasOncoradiology Center, Uzsoki Hospital, Uzsoki u. 29-41, Budapest, 1145, Hungary.
Kornélia Borbásné FarkasUnicersity of Pécs, Medical School, Institute of Bioanalysis, Szigeti út 12, Pécs, 7624, Hungary.
Klára SebestyénClinical Center, Department of Oncotherapy, University of Pécs, Édesanyák útja 17, Pécs, 7624, Hungary.
Zsolt SebestyénClinical Center, Department of Oncotherapy, University of Pécs, Édesanyák útja 17, Pécs, 7624, Hungary.
Zoltán MuschClinical Center, Department of Oncotherapy, University of Pécs, Édesanyák útja 17, Pécs, 7624, Hungary.
Ágnes VojcekOncology Unit, Clinical Center, Department of Pediatrics Pécs, University of Pécs, József Attila út 7, Pécs, 7623, Hungary.
Noémi BenedekOncology Unit, Clinical Center, Department of Pediatrics Pécs, University of Pécs, József Attila út 7, Pécs, 7623, Hungary.
László MangelClinical Center, Department of Oncotherapy, University of Pécs, Édesanyák útja 17, Pécs, 7624, Hungary.
Gábor OttóffyOncology Unit, Clinical Center, Department of Pediatrics Pécs, University of Pécs, József Attila út 7, Pécs, 7623, Hungary.
University of Pecs · HUUzsoki Hospital · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCraniospinal irradiation (CSI) of childhood tumors with the RapidArc technique is a new method of treatment. Our objective was to compare the acute hematological toxicity pattern during 3D conformal radiotherapy with the application of the novel technique.

methodsData from patients treated between 2007 and 2014 were collected, and seven patients were identified in both treatment groups. After establishing a general linear model, acute blood toxicity results were obtained using SPSS software. Furthermore, the exposure dose of the organs at risk was compared. Patients were followed for a minimum of 5 years, and progression-free survival and overall survival data were assessed.

resultsAfter assessment of the laboratory parameters in the two groups, it may be concluded that no significant differences were detected in terms of the mean dose exposures of the normal tissues or the acute hematological side effects during the IMRT/ARC and 3D conformal treatments. Laboratory parameters decreased significantly compared to the baseline values during the treatment weeks. Nevertheless, no significant differences were detected between the two groups. No remarkable differences were confirmed between the two groups regarding the five-year progression-free survival or overall survival, and no signs of serious organ toxicity due to irradiation were observed during the follow-up period in either of the groups.

conclusionThe RapidArc technique can be used safely even in the treatment of childhood tumors, as the extent of the exposure dose in normal tissues and the amount of acute hematological side effects are not higher with this technique.

Indexed as

AdolescentAdultAnalysis of VarianceBlood CellsBrain NeoplasmsChildChild, PreschoolCraniospinal IrradiationFollow-Up StudiesHumansLiverOrgans at RiskPelvic BonesProgression-Free SurvivalRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedChildhood cancerCraniospinal irradiationMedulloblastomaRapidArc

Identifiers

PMID32727407
PMCPMC7388493
OpenAlexW3045932712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.